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ABSTRACT 
Pro- and anti-inflammatory cytokines are supposed to be involved in malaria 
pathogenesis. Their relationship with clinical manifestations of the disease, however, is 
rarely studied in adults from non-endemic countries with imported disease, particularly 
with severe malaria. In this study we compared serum levels of gamma interferon 
(IFNγ) and interleukins: IL-12, IL-18, IL-10 in healthy adults and patients with severe  
or uncomplicated imported malaria, with predominance of Plasmodium falciparum and 
Plasmodium vivax infections within studied group. Severe malaria was shown to be 
associated with elevated serum levels of IFNγ and IL-18 as well as with relative 
deficiency of IL-12 mediated response in comparison to uncomplicated malaria cases, 
while IL-10 was found to be higher in all malaria patients compared to the controls. 
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Overall, the results of our study are consistent with the observations from the regions 
with holoendemic malaria transmission, suggesting a pivotal role of impaired IL-12 
expression in severe malaria. On the contrary, patients with severe malaria included into 
our study presented with the pattern of excessive production of inflammatory IFNγ and 
IL-18, what seems to be an unusual finding compared to the results of the studies on 
African children and may be the feature of severe malaria in non-immune adults. 
BACKGROUND 
As a major cause of morbidity and mortality in many tropical regions of the world, 
malaria still remains an important global public health concern. In non-endemic 
countries imported malaria is a rare, but serious clinical problem, with non-immune 
adults returning from travel in endemic areas being susceptible to severe manifestations 
of Plasmodium falciparum infection [1, 2]. Growing problem of antimalarial drug 
resistance and lack of an effective vaccine makes the insight into the complex 
pathogenesis of malaria vital for the development of new therapeutic tools and control 
of the disease.  
Cytokines seem to be involved both in protection and pathology in malaria 
infection. Early and effective inflammatory response, mediated by gamma interferon 
(IFN-γ) in the interleukin 12 (IL-12) and 18 (IL-18) dependent manner, seems to be 
crucial for the control of parasitaemia and resolution of malaria infection through the 
mechanisms of the tumor necrosis factor α (TNFα) induction and enhanced release of 
the antiparasitic reactive nitrogen and oxygen radicals [3-4]. On the other hand, severe 
malaria has long been associated with high circulating levels of proinflammatory 
cytokines such as TNFα, IFN-γ, interleukin 1 (IL-1) and interleukin 6 (IL-6) [4-5]. 
Their excessive production may affect the disease outcome through their direct systemic 
effect and by increasing cytoadherence of parasitized erthrocytes to the endothelium via 
upregulation of adhesion molecules in Plasmodium falciparum infections [6]. The 
expression of cytokines in general as well as the balance of pro- and antiinflammatory 
response are supposed to be involved in malaria pathogensis, but their relationship with 
the pattern and extent of vital organ dysfunction in malaria infection has not been well 
defined yet. Severe malarial anaemia has been associated with low serum levels of IL-
12 and low interleukin 10 (IL-10) to TNFα serum concentrations ratio in a few studies 
of childhood malaria in holoendemic areas [7-9]. However, the manifestations of severe 
malaria vary with geographic location and malaria transmission intensity as well as with 
the age of the patient [1, 6, 10]. In non-immune adults severe malaria often presents as a 
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multiorgan disorder with renal failure, hepatic dysfunction with jaundice and shock 
while in African children cerebral malaria and severe anaemia predominate [2, 6]. 
Recent in vitro experiments have shown that peripheral blood mononuclear cells from 
clinically immune individuals from areas of high endemicity produce lower amounts of 
IFN-γ in response to P. falciparum schizont antigens than those from previously 
unexposed donors, indicating that the control of clinical symptoms may depend on the 
host ability to regulate strictly the inflammatory response [11]. Studies in mice 
undergoing primary malaria infection have suggested that the profile of cytokines, 
including IFN-γ, released early in the course of the infection, may predict the final 
outcome of the disease [3, 12]. Data concerning involvement of cytokines in naturally 
acquired malaria infection in non-immune adults, particularly with severe 
manifestations of the disease, are scarce. 
OBJECTIVE 
The aim of this study was to evaluate the relationship between clinical 
manifestations of malaria infection and the serum levels of pro- and anti-inflammatory 
cytokines  in adult patients with uncomplicated and severe malaria.  
 
MATERIAL AND METHODS 
 
Thirty four adult patients with a diagnosis of malaria acquired during touristic or 
professional stay in endemic areas, admitted in the years 1995 to 2004 to the Clinic of 
Tropical and Parasitic Diseases of the Interfaculty Institute of Maritime and Tropical 
Medicine of the Medical University of Gdańsk were included in the study.  
Malaria was confirmed either by examination of thick and thin peripheral blood 
smears or by polymerase chain reaction (PCR) method. Quantitive parasite counts were 
reported  from thin blood films as the percents of parasitized erythrocytes in 500 red 
blood cells, and the level of antimalarial antibodies in serum of all patients was also 
measured with the use of indirect immunofluorescence antibody test (IFA) [13]. A full 
history was taken from each patient and a detailed physical examination was performed 
on admission. Peripheral venous blood samples were taken from all patients for 
biochemical and hematological assessment as well as for serum cytokines concentration 
measurement.  
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Patients received adequate antimalarial treatment and were followed up until 
discharge from hospital or death. Basing on the results of laboratory and clinical 
findings during hospitalization patients were divided into two groups according to the 
severity of the disease. Severe and uncomplicated malaria cases were distinguished with 
the use of criteria based on World Health Organisation description of severe 
manifestations and complications of malaria, as shown in the table 1 [1, 10]. 
 
Table 1.  Entry criteria of severe malaria group (see references 1 and 10) 
Impaired consciousness 
Prostration – inability to sit unassisted 
Acidosis  – arterial pH < 7,25 or venous lactate level > 15 mmol/L 
Multiple convulsions  
Circulatory collapse 
Pulmonary oedema or Acute Respiratory Distress Syndrome 
Abnormal bleeding 
Jaundice – serum bilirubin concentration of > 3 mg/dL 
Macroscopic haemoglobinuria 
Severe anaemia – haemoglobin of < 7 g/dL or haematocrit <20% 
Renal failure – urine output <400 mL/24hrs or serum creatinine level >3 mg/dL 
Hypoglycaemia – serum glucose level of < 40 mg/dL 
Hyperparasitaemia – > 5%  
Hyperpyrexia – temperature >40o C 
 
Eight healthy Polish adults with no history of travel to malaria endemic areas were 
recruited to the study as a control group for cytokines determination. 
Blood samples for cytokines measurement were collected within twenty four hours 
from admission, centrifuged immediately at 4000 g for 5 minutes and stored at –70oC 
until analysis. Serum concentrations of IFN-γ, IL-12, IL-18, IL-10 were determined 
using enzyme-linked immunosorbent assays obtained commercially (ELISA, 
BenderMedSystems, Austria). All specimens were measured in duplicate and the mean 
of the two values was taken for the analysis. The sensitivity of these assays, as defined 
by manufacturer, are 0.27 pg/ml, 19.1 pg/ml, 55 pg/ml, 0.05 pg/ml respectively. 
Comparisons between two groups were performed using the nonparametric Mann-
Whitney U-test. Correlations between continuous variables were assessed with the 




Among 34 adult patients included into the study, 22 persons were diagnosed as 
Plasmodium falciparum cases,  8 as P. vivax cases and one had mixed infection  
(P. falciparum and P. vivax). Moreover, 2 cases of P. ovale infection and one of  
P. malariae were found in the studied group. Twenty-seven patients had uncomplicated 
malaria, while 7 developed severe malaria (all of them P. falciparum infection). The 
titre of antimalarial antibodies measured with the IFA test was higher than 1:80 in 21 
patients, in 10 patients it was equal or lower than 1:80 and in 3 patients it was not 
examined. The results of the laboratory blood examinations of 34 patients are 
summarized in Table 2. 
The  following clinical manifestations of severe form of the disease were observed 
in the studied group: impairment of consciousness including cerebral malaria, renal 
failure, acidosis, severe prostration, hyperparasitaemia, jaundice and hyperpyrexia, as 
shown in  Table 3. One patient died in the result of multi-organ failure. 
 
Table 2. Results of the laboratory blood examinations of 34 malaria patients 




Age (yr) * 39,6 ± 11,5 35,7 ± 9,9 
№ male/ № female 24 / 3 7 / 0 
Temp. (oC) * 37,9 ± 1,11 38,7 ± 0,82 
Parasitaemia (%) * 0,34 ± 0,47 3,6 ± 3,02 
Haemoglobin (g/dL) * 11,55 ± 1,76 11,05 ± 1,79 
Platelet count (106/L) * 130,8 ± 79,87 50,4 ± 18,62 
Bilirubin serum level (mg/dL) * 1,2 ± 0,65 2,7 ± 2,47 
Glucose serum level (mg/dL) * 97,5 ± 18,62 97 ± 7,62 
Creatinine serum level (mg/dL) * 1,1 ± 0,23 2,39 ± 3,1 




Table 3. Manifestations of severe malaria in the studied group of 34 patients 
Clinical feature № of cases* 
Impaired consciousness 2 






* Total number exceeds 7 as some patients presented with more than one feature 
of severe malaria.  
 
No significant differences between mean serum concentrations of any measured 
cytokine were observed in patients divided into groups according to different species of 
Plasmodium they were infected with. However, several associations between both pro- 
and anti-inflammatory cytokines serum levels and the severity of the disease were 
noted.  
Mean serum level of IFN-γ was found to be significantly higher in  severe as well 
as uncomplicated malaria group compared to the controls (23,71 pg/ml vs 1,40 pg/ml; 
109 
p<0,01 and 4,23 pg/ml vs 1,40 pg/ml; p<0,05 – respectively, as in the fig. 1). Moreover, 
the mean serum concentration of IFN-γ was significantly higher in patients reporting 
their primary symptomatic Plasmodium infection, than in those with the history of more 
than one malaria infections (13,73 pg/ml vs 3,13 pg/ml; p<0,05 - respectively). 
As far as IL-12 is concerned (fig. 2), a significant difference was observed between 
its mean serum concentration in uncomplicated malaria patients compared to the 
controls (191,99 pg/ml vs 6,84 pg/ml with p<0,05), but its level was lower in patients 
with severe manifestation of the disease in comparison to those with uncomplicated 
malaria (102,49 pg/ml vs 191,99 pg/ml with p<0,05).  
 
On the contrary, mean serum level of IL-18 was higher in severe malaria patients 
than in uncomplicated disease group and the control group (1255,22 pg/ml vs 
390,30;p<0,05 and 1255,22 pg/ml vs 299,25 pg/ml; p<0,05, respectively). In addition, 
association was found between IL-12/IL-18 serum concentrations ratio and the disease 
severity (0,12 in severe vs 1,08 in mild malaria, p<0,01).  
Mean serum level of IL-10 was significantly higher in both severe and 
uncomplicated malaria patients than in the controls (45,19 pg/ml vs 1,65 pg/ml; p<0,01  
and 28,69 pg/ml vs 1,65 pg/ml; p<0,0001, respectively).  
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Similar relations regarding all mentioned cytokines were seen between severe and 
uncomplicated malaria patients within groups confined to Plasmodium falciparum 
infected individuals.  
No significant correlation of cytokines levels and parasitaemia or the level of 
malarial antibodies was found in the studied group. 
DISCUSSION 
In this study we demonstrated the relations between a number of both pro- and anti-
inflammatory type cytokines expression and the degree of severity and outcome pattern 
of malaria infection in adult patients. Detailed analysis showed uncomplicated 
manifestation of the disease is associated with elevated serum levels of IL-12 as well as 
IFN-γ in comparison with the values measured in the sera of the healthy controls. As a 
potent immunomodulatory cytokine, IL-12, released by macrophages in response to 
infectious agents, is involved in cell-mediated immune response via Th1 cells induction. 
The latter produce IFN-γ, which in turn is supposed to enhance TNFα, reactive nitrogen 
and oxygen radicals production what seems to be essential for the resolution of malaria 
infection [4]. IL-12 serum level turned out to be significantly lower in severe compared 
to mild malaria patients in our observations, what is consistent with most of the studies 
carried out in endemic regions [7, 9, 14, 15]. Several mechanisms of IL-12 low activity 
in severe malaria had been previously suggested i.e. suppressive activity of anti-
inflammatory cytokines such as IL-10 or macrophage activity impairment due to 
malaria pigments [9, 14]. Genetic factors were also proposed to explain that 
phenomenon basing on the results of animal model studies. Overall, our study is 
consistent with the hypothesis of the pivotal role of IL-12 for the control of the disease 
severity. Studies carried out in Africa associated defective IL-12 production with severe 
malarial anaemia, which is a common feature of Plasmodium falciparum infection in 
children there. Either a direct role of IL-12 defective production in erythropoiesis or its 
influence on protective immune responses in general, were suggested to be involved in 
the development of severe anaemia during malaria infection. However, we did not 
observe any case of profound anaemia among our patients with low IL-12 serum level, 
what seems to support rather the latter mechanism of IL-12 participation in severe 
manifestations of the disease. In addition, several studies on African children associated 
severe malaria with reduced IFN-γ activity [14,16]. This is in contrast to the results of 
our study, since we demonstrated that high IFN-γ serum level is clearly linked to the 
disease severity. Overproduction of IFN-γ leading to severe pathology may be the 
feature of malaria infection in non-immune adults [3]. This seems to be supported by 
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recent in vitro experiment, in which peripheral blood mononuclear cells from clinically 
immune residents of high malaria transmission region produce less IFN-γ in response to 
P. falciparum antigens, than those from unexposed donors [11]. Interestingly, in our 
study patients with the history of previous malaria infections had significantly lower 
serum IFN-γ concentrations than those reporting the disease as their primary.  
Significant elevation of IFN-γ level in severe malaria patients of our study was 
accompanied by high IL-18 concentrations, what is also an unusual pattern regarding 
the results of the studies on childhood malaria from endemic areas,  demonstrating in 
most cases the opposite relation between IL-18 level and the disease severity there 
[7,17-19]. In rodent studies treatment with IL-18 was shown to increase IFN-γ levels in 
mice infected with P. yoelli and P. berghei leading to a delay in the onset of 
parasitaemia and better survival rate [20]. In humans, proinflammatory role of IL-18 in 
Plasmodium spp. infection as well as the capability of IFN-γ induction had been 
suggested to play role in protective responses in a few studies concerning children. In 
our observations, excessive production of both of these molecules was associated with 
severe forms of malaria infections, what is consistent with the results of one study on 
adult patients with severe and uncomplicated malaria carried out in Thailand [21].  
Moreover, we found that IL-12/IL-18 serum levels ratio is much lower in patients with 
severe clinical manifestations than in individuals with uncomplicated malaria, what 
supports our observation that severity of the infection is related to  IL-18 dependent 
IFN-γ overproduction, linked with impaired IL-12 activity. The reasons for this 
phenomenon are not clear, however. High levels of IL-10 found in the sera of severe 
malaria patients may contribute to IL-12 suppression as suggested before, but on the 
other hand this may be insufficient to control the inflammatory cascade mediated by IL-
18 along with IFN-γ. Down-regulation of human monocyte IL-12 production, in the 
absence of similar effects on other proinflammatory cytokines, is a well documented  
phenomenon [14].  
In all but one of the patients included in our study, other coexistent parasitic 
infections were excluded basing on detailed, routine diagnostic examinations. Most of 
the studies carried out in malaria endemic areas do not take this circumstance into 
consideration. However, children from rural African regions are likely to be infected 
simultaneously with more than one pathogen prevalent in tropical countries and  
coincidental parasitic infections may  interfere with cytokines released in Plasmodium 
spp. infection. This may partially contribute to differences in the results of studies on 
populations of malaria endemic countries and our results. 
In our study, the peripheral parasite count was not associated with any cytokine 
serum concentration, neither were the parasite species. Thus, apart from parasite-related 
factors and mechanisms acquired with previous exposures, conceivable host factors may 
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be supposed to affect the regulation of cytokines expression. Similarly as in the case of 
other cytokines involved in malaria infection, i.e. TNFα, their production may be 
controlled at gene level [4]. Other molecules, which were not assessed in our study as 
well as the influence of soluble cytokine receptors could also be taken into 
consideration, while explaining the mechanisms of our observations.  
CONCLUSIONS 
In summary, the results of our study support the hypothesis that effective 
Plasmodium spp. infection resolution along with uncomplicated clinical manifestation 
of the disease and the favorable outcome depend on strict regulation of pro- and anti-
inflammatory responses mediated by relevant cytokines. The excessive inflammatory 
response pattern demonstrated by high IFN-γ and IL-18 expression and relative IL-12 
deficiency in the individuals included in our study may be the common feature of severe 
malaria in adults with imported disease. However, the results of these study should be 
considered as preliminary, therefore further studies are needed on larger group of 
patients to determine the cytokines involvement in particular clinical manifestations of 
the disease. 
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